Medgadget Review: FlipPad, A Rugged Antimicrobial iPad Case
Conclusion: If you need to keep your iPad perfectly clean and useful in a clinical environment, the FlipPad is about the only real choice out there. The various usability features make it practical and ergonomic for daily use, something the FlipPad has proven to us during our two weeks with it in the hospital.
Product page: FlipPad…
This post Medgadget Review: FlipPad, A Rugged Antimicrobial iPad Case appeared first on Medgadget. (Source: Medgadget)
Source: Medgadget - October 31, 2016 Category: Medical Equipment Authors: Editors Tags: Exclusive Source Type: blogs
Why the United Nations General Assembly Session on Antimicrobial Resistance Matters
Many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in longer illnesses and more deaths. The fact that world leaders are using the UN as a forum for discussions about AMR is a promising move toward developing a coordinated global plan. (Source: The RAND Blog)
Source: The RAND Blog - September 18, 2016 Category: Health Management Authors: RAND Corporation Source Type: blogs
European and American Efforts to Tackle AMR: Great Minds Think Alike (Almost Always)
The U.S. and the EU are committed to tackling antimicrobial resistance. Their efforts share objectives around key areas for improvement, such as the stewardship of existing antimicrobials, surveillance of their use, and development of new antimicrobials. (Source: The RAND Blog)
Source: The RAND Blog - August 18, 2016 Category: Health Management Authors: RAND Corporation Source Type: blogs
European and American Efforts to Tackle AMR: Great Minds Think Alike (Almost Always)
By JIRKA TAYLOR and ELTA SMITH
Antimicrobial resistance (AMR) is a major threat to public health and the global economy. Indeed, a RAND Europe study found that failure to address AMR could result in worldwide economic losses of $3 trillion and annual population decreases of 10 million people every year until 2050.
In May 2016, the UK’s Review on AMR, headed by economist Jim O’Neill, delivered its final report, which stressed the need to find global and cooperative international solutions. It is good news then that the United States and European Union (EU) are among the most important international actors in this a...
Source: The Health Care Blog - August 17, 2016 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Source Type: blogs
What if antibiotics were to stop working?
The King's Fund - The NHS if is a collection of essays that explores hypothetical scenarios and their impact on the future of health and care. Our aim is to encourage new thinking and debate about possible future scenarios that could fundamentally change health and care. This essay, by Professor Dame Sally Davies and Rebecca Sugden, explores a future in which antimicrobial resistance changes the face of medicine and health care.EssayThe NHS if (Source: Health Management Specialist Library)
Source: Health Management Specialist Library - August 16, 2016 Category: UK Health Authors: The King ' s Fund Information & Knowledge Service Tags: Local authorities, public health and health inequalities Quality of care and clinical outcomes Source Type: blogs
The Global Economic Costs of Antimicrobial Resistance
In addition to being a public health problem, antimicrobial resistance is also a major economic concern. It crosses sectoral boundaries, because resistant bugs can pass between animals and humans, and through food, agriculture, and the environment. (Source: The RAND Blog)
Source: The RAND Blog - May 19, 2016 Category: Health Management Authors: RAND Corporation Source Type: blogs
The O'Neill Review: A Critical Step in Taking Global Action Against AMR
The O'Neill Review aims to increase global knowledge of antimicrobial resistance (AMR) and generate international consensus about the nature of the problem and the necessary steps to tackle it. A RAND Europe analysis of the potential economic costs of AMR contributed to the Review. (Source: The RAND Blog)
Source: The RAND Blog - May 18, 2016 Category: Health Management Authors: RAND Corporation Source Type: blogs
Tackling drug-resistant infections globally: final report and recommendations
This report outlines the Review’s final recommendations. It first discusses the mounting problem of resistance and why action is needed to combat it and then provides an overview of the solutions that the Review thinks should be implemented to curtail unnecessary use and increase the supply of new antimicrobials. It then looks at the role of public awareness campaigns, the need to improve sanitation and hygiene, reduce pollution from agriculture and the environment, improve global surveillance, introduce rapid diagnostics and vaccines, the need to increase the number of people in this area, and use of market entry reward...
Source: Health Management Specialist Library - May 18, 2016 Category: UK Health Authors: The King's Fund Information & Knowledge Service Tags: Local authorities, public health and health inequalities Source Type: blogs
Antimicrobial stewardship quality standard
National Institute for Health and Care Excellence (NICE) - This quality standard aims to help health care professionals and organisations tackle the problem of antimicrobial resistance. It contains six statements which health care professionals can use to lower antimicrobian resistance and improve the quality of data tracking in the NHS.
Quality standard
Press release (Source: Health Management Specialist Library)
Source: Health Management Specialist Library - April 24, 2016 Category: UK Health Authors: The King's Fund Information & Knowledge Service Tags: Local authorities, public health and health inequalities Quality of care and clinical outcomes Workforce and employment Source Type: blogs
To Fight Antimicrobial Resistance, Allow FDA To Approve New Drugs For Limited Populations
Over the past several months, microbiologists and public health experts around the world have been alarmed by the discovery of a gene conferring resistance to colistin, a so-called “last resort” antibiotic.
The gene, MCR-1, was discovered in China last year, and thereafter quickly identified in E. coli samples from six continents. Because this type of gene is highly transferable, it will, in all likelihood, spread to other hard-to-treat bacteria. What global health leaders have been warning of for years has now become reality.
Now, more than ever, there is an urgent need for action to spur the innovation of antibiotics...
Source: Health Affairs Blog - April 5, 2016 Category: Health Management Authors: Allan Coukell Tags: Drugs and Medical Technology Featured Global Health Population Health Public Health Quality 21st Century Cures Act Antibiotic Resistance Antibiotics Congress FDA limited-population antibacterial drug MCR-1 PATH Act Research Source Type: blogs
FDA 2015: A Look Back (and Ahead) – Part 3: Food, Tobacco, and Antimicrobial Resistance
By: Stephen M. Ostroff, M.D. In my third and final post reflecting on FDA’s work to protect and promote public health in 2015, we’ll take a look at our achievements in food, antimicrobial resistance, and tobacco product regulation. Modernizing Food … Continue reading → (Source: FDA Voice)
Source: FDA Voice - January 23, 2016 Category: American Health Source Type: blogs
Antibiotics: Preserve the miracle?
The placebo effect is well-known in modern medicine. Unfortunately, the most effective medicines we’ve ever discovered are more often used as placebos rather than cures. What are these medicines? Antibiotics.
They’ve added 20 years to the average human life expectancy, some would call this a “miracle”. In-fact “preserve the miracle” is the official slogan for Antibiotic Awareness Week. But it’s a word that carries some baggage, after all miracles don’t come with adverse consequences.
Antibiotics, like other medicines have side-effects. In the patient these can range from allergies and Stevens-Johnson syndro...
Source: Life in the Fast Lane - January 20, 2016 Category: Emergency Medicine Authors: Jarrad Hall Tags: Immunology Infectious Disease Microbiology antibiotics Faustian bargain placebo resistance Source Type: blogs
Alcohol problems in middle-aged women
Louise Newson discusses the findings of a recent OECD reportRelated items from OnMedicaDoctors demand action on drinking in pregnancyPatient safety alert issued on antimicrobial resistance Nurse CoachingOver 215,000 people signed up to StoptoberPatients less happy with low antibiotic prescribers (Source: OnMedica Blogs)
Source: OnMedica Blogs - December 21, 2015 Category: Journals (General) Source Type: blogs
Drinking in pregnancy
What should we be advising pregnant women regarding drinking alcohol?Related items from OnMedicaPatient safety alert issued on antimicrobial resistance Doctors and midwives welcome clear alcohol adviceDoctors demand action on drinking in pregnancyAlcohol-related deaths rise 5% in a yearNICE tackles public over antimicrobials (Source: OnMedica Blogs)
Source: OnMedica Blogs - October 14, 2015 Category: Journals (General) Source Type: blogs
The 21st Century Cures Act: More Homework To Do
In July, the US House of Representatives approved the 21st Century Cures Act, which heads to the Senate for a vote this fall. While no one can complain about the Act’s purported goal of “bring[ing] our health care innovation infrastructure into the 21st Century,” or increasing funding for the National Institutes of Health, the optimism surrounding the legislation obscures measures buried within that many agree will make newly approved drugs and medical devices less safe and effective, increase the cost of medical products, and discourage innovation in biomedical research.
Long-term value to the public’s health is b...
Source: Health Affairs Blog - September 24, 2015 Category: Health Management Authors: Susan Molchan, James Rickert and John Powers Tags: Costs and Spending Drugs and Medical Technology Featured Health Professionals Hospitals Public Health Quality 21st Century Cures Act Big Pharma Drug approval Fred Upton Research funding Thurgood Marshall Source Type: blogs
